Risk of Early Death and Recurrent Stroke and Effect of Heparin in 3169 Patients With Acute Ischemic Stroke and Atrial Fibrillation in the International Stroke Trial | Zendy

Ritu Saxena | Zendy; Steff Lewis | Zendy; Eivind Berge | Zendy; Peter Sandercock | Zendy; Peter J. Koudstaal | Zendy

Open Access

Risk of Early Death and Recurrent Stroke and Effect of Heparin in 3169 Patients With Acute Ischemic Stroke and Atrial Fibrillation in the International Stroke Trial

Author(s) -

Ritu Saxena,

Steff Lewis,

Eivind Berge,

Peter Sandercock,

Peter J. Koudstaal

Publication year - 2001

Publication title -

stroke

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.397

H-Index - 319

eISSN - 1524-4628

pISSN - 0039-2499

DOI - 10.1161/hs1001.097093

Subject(s) - medicine , stroke (engine) , atrial fibrillation , aspirin , cardiology , anesthesia , surgery , mechanical engineering , engineering

We sought to investigate the apparently high risk of early death after an ischemic stroke among patients with atrial fibrillation (AF), identify the main factors associated with early death, and assess the effect of treatment with different doses of subcutaneous unfractionated heparin (UFH) given within 48 hours.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research